06:00 PM EDT, 10/27/2025 (MT Newswires) -- Wendell Wierenga, Director, on October 27, 2025, sold 4,375 shares in Cytokinetics ( CYTK ) for $256,725. Following the Form 4 filing with the SEC, Wierenga has control over a total of 32,444 common shares of the company, with 32,444 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198325000026/xslF345X05/form4.xml